|
|
||||||||||
|
J Am Coll Cardiol, 2007; 49:986-992, doi:10.1016/j.jacc.2006.10.062
(Published online 15 February 2007). © 2007 by the American College of Cardiology Foundation |


* Division of Cardiovascular Disease and Internal Medicine, Mayo Clinic, Rochester, Minnesota.
Section of Biostatistics, Mayo Clinic, Rochester, Minnesota.
Manuscript received March 27, 2006; revised manuscript received October 19, 2006, accepted October 23, 2006.
* Reprint requests and correspondence: Dr. Teresa S. M. Tsang, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. (Email: tsang.teresa{at}mayo.edu).
Objectives: The purpose of this study was to assess the mortality trends of atrial fibrillation (AF) in a community.
Background: Limited data exist regarding the mortality trends of patients diagnosed with first AF.
Methods: A community-based cohort of adult residents of Olmsted County, Minnesota, who had electrocardiogram-confirmed first-documented AF in the years 1980 to 2000 were identified and followed to 2004 or death. The primary outcome was all-cause mortality.
Results: Of a total of 4,618 residents (mean age 73 ± 14 years) diagnosed with first AF, 3,085 died during a mean follow-up of 5.3 ± 5.0 years. Relative to the age- and gender-matched general Minnesota population, the mortality risk was increased (p < 0.0001) with a hazard ratio (HR) of 9.62 (95% confidence interval [CI] 8.93 to 10.32) within the first 4 months and 1.66 (95% CI 1.59 to 1.73) thereafter. Cox proportional hazards modeling showed no change in overall age- and gender-adjusted mortality (HR for the year 2000 vs. 1980: 0.99; 95% CI 0.86 to 1.13; p = 0.84), even after adjustment for comorbidities. In secondary analyses, no changes in mortality were seen for early (within first 4 months) or late (after 4 months) mortality for the entire group or within the subgroup of patients who did not have cardiovascular disease at baseline.
Conclusions: In this cohort of patients newly diagnosed with AF, mortality risk was high, especially within the first 4 months. There was no evidence for any significant changes over the 21 years in terms of overall mortality, early or late mortality, or mortality among patients without pre-existing cardiovascular disease.
| |||||
This article has been cited by other articles:
![]() |
J. S. Taggar, F. Marin, and G. Y.H. Lip Mortality in patients with atrial fibrillation: improving or not? Europace, April 1, 2008; 10(4): 389 - 390. [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz and F. A. Masoudi The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2254 - 2262. [Full Text] [PDF] |
||||
![]() |
Other articles noted Evid. Based Med., August 1, 2007; 12(4): 127 - 128. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |